CSF2 and influenza: Hence, preexisting pulmonary diseases, as well as influenza-mediated lung injury in itself, induces a porous lung vasculature/epithelium that facilitates the escape of GM-CSF from the alveolar space, reducing its effectiveness as a therapeutic agent.